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Middle East and North AfricaA B S T R A C T
Aims: We developed and demonstrated a novel mathematical modeling approach to fore-
cast the burden of type 2 diabetes mellitus (T2DM) and to investigate T2DM epidemiology
for the purpose of informing public health policy and programming.
Methods: A population-level compartmental mathematical model was constructed and
applied to Qatar. The model was stratified according to sex, age group, risk factor status,
and T2DM status, and was parameterized by nationally-representative data.
Results: T2DM prevalence increased from 16.7% in 2012 to at least 24.0% by 2050. The rise in
T2DM was most prominent among 45–54 years old. T2DM health expenditure was esti-
mated to increase by 200–600% and to account for up to 32% of total health expenditure
by 2050. Prevalence of obesity, smoking, and physical inactivity was predicted to increase
from 41.4% to 51.0%, from 16.4% to 19.4%, and from 45.9% to 53.0%, respectively. The pro-
portion of T2DM incidence attributed to obesity, smoking and physical inactivity was esti-
mated at 57.5%, 1.8%, and 5.4%, respectively in 2012, and 65.7%, 2.1%, and 6.0%, respectively
in 2050. Exploring different scenarios for the trends in risk factors, T2DM prevalence
reached up to 37.7% by 2050.
Conclusions: Using our innovative approach, a rising T2DM epidemic is predicted to con-
tinue in the next decades, driven by population growth, ageing and adverse trends in risk
factors. Obesity was the principal risk factor explaining two-thirds of T2DM incidence.
T2DM must be a national priority addressed by preventive and therapeutic interventions
targeting T2DM and its modifiable risk factors.
 2017 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The burgeoning epidemic of diabetes mellitus (DM) is an
eminent global health challenge of the 21st century [1] witha predicted 642 million people living with DM by 2040 [2].
The Middle East and North Africa (MENA) is projected to have
one of the largest proportional increases in the number of
adults with DM by 2040 (96.2%) [2,3].ation City,
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enced by several demographic and socio-behavioral health
determinants [2]. Socio-demographic factors include global-
ization, urbanization, and increased life expectancy [4,5],
while behavioral risk factors include obesity (BMI > 30 kg/m
2) [6–8] smoking [9,10], and physical inactivity [11,12] among
others.
In the first national population-based survey in 2012 [13],
Qatar, part of MENA, reported a DM prevalence (for diagnosed
and undiagnosed T2DM and Type 1 DM) of 16.7% (95% confi-
dence interval [CI] 13.7–19.8) among adult Qatari nationals
aged 18–64 years old; the tenth highest globally [14]. Preva-
lences of obesity, active smoking, and physical inactivity were
reported in this survey as being 41.4% (95% CI 38.8–44.0),
16.4% (95% CI 14.3–18.4), and 45.9% (95% CI 42.2–49.6), respec-
tively [13]. Accordingly, assessing the future T2DM burden in
Qatar and its risk factors is critical to inform national public
health policy, programming and resource allocation.
Several modeling studies projected DM prevalence in
Qatar within the context of global estimations [14–21]. While
factoring population aging, all assumed a constant age-
specific DM prevalence over time [14–20]—an unrealistic
assumption considering predicted increases of key risk fac-
tors in MENA [3,22]. While these models are informative, they
do not capture dynamically the interactions and trends of risk
factors, demography, and T2DM natural history, and are not
amenable to assessments of impact of interventions against
risk factors.
Against this background, we developed a dynamic fore-
casting and age-structured mathematical model for T2DM, a
novel analytic framework, to (i) predict future T2DM preva-
lence and incidence, (ii) estimate health expenditures directly
attributed to T2DM, and (iii) evaluate the effects of key risk
factors and their complex overlap on T2DM. A key strength
of our approach is its detailed stratification of the key risk fac-
tors of obesity, smoking, and physical inactivity and all of
their possible overlaps. We present the methodological
approach and results, as applied to Qatar, which can be
applied across countries. This analytic framework can be also
used to assess impact of interventions against T2DM and risk
factors.
2. Subjects, materials and methods
We constructed a deterministic compartmental mathemati-
cal model that describes the development of T2DM in a given
population—in this case, the Qatari population. The model
was based on and informed by existing modeling approaches
for non-communicable [23] and communicable diseases [24],
andwas structured to represent and utilize available epidemi-
ological data. The model was parameterized using nationally-
representative epidemiological and demographic data and
programmed in MATLAB version 2015a [25].
2.1. Mathematical model
The model describes the four dimensions of sex, age, risk fac-
tor status, and T2DM status for a given population leading to a
set of 640 differential equations that stratify the populationbased on these four dimensions (Appendix Fig. S1). Themodel
disaggregates the population into 20 five-year age bands (0–4,
5–9. . . 95–99 years old) and incorporates four main susceptible
classes: healthy (i.e. non-obese, non-smoker, physically
active, and non-diabetic), obese, smoker, and physically inac-
tive. It accounts for overlaps between risk factors by further
stratifying the susceptible population into compartments
with overlapping risk factors. Further details on model struc-
ture and assumptions can be found in Appendix Text S1.
2.2. Data sources and model fitting
The model was parameterized using epidemiological and nat-
ural history data, listed in Appendix Table S1. Further discus-
sion of parameter values is provided in Appendix Text S1.
Themodelwasfitted to sex- andage-specificT2DM, obesity,
smoking and physical inactivity prevalence data using a non-
linear least-square fitting method [25]. Seven sex- and age-
specific measures were derived by generating the best fit:
T2DM baseline incidence rate (i.e. incidence rate from
‘‘healthy” to T2DM), transition rates from healthy to obese,
obese tohealthy, healthy to smoker, smoker tohealthy, healthy
to physically inactive, and physically inactive to healthy.
2.3. Plan of analysis and estimating T2DM and risk
factors’ future trends
We used the best-fit parameters to predict trends in T2DM
prevalence and incidence among Qataris aged 15–64 years
between 2012 and 2050. The year 2012 was the baseline year,
representing Qatar’s only measured prevalence data.
Predicted risk factor trends and their effects on T2DMwere
also estimated between 2012 and 2050. The latter were esti-
mated by calculating the total T2DM incident cases attributed
to each risk factor, through population attributable fraction
(PAF) approach. We adjusted for the overlap between risk fac-
tors using an adaptation of established PAF methodologies
[26–28].
2.3.1. The effect of future trends in risk factors on T2DM
We investigated effects of risk factors on T2DM prevalence
through five forecast scenarios. The trends in prevalence of
smoking, obesity and physical inactivity in Qatar between
2012 and 2050 were based on WHO’s country specific esti-
mates [29,30].
Scenario 1: Forecast scenario assuming constant age-specific risk
factor prevalences (demographic change only)
We assumed the age-specific risk factor prevalences
remained the same between 2012 and 2050. Accordingly,
trends in risk factors depend only on the demographic struc-
ture of the population. This was the baseline scenario for
comparison.
Scenario 2: Forecast scenario based on increase in obesity
We assumed an annual increase of 1.05% in obesity preva-
lence [30] and no change in smoking and physical inactivity.
Fig. 1 – Projected type 2 diabetesmellitus (T2DM) among Qataris between 2012 and 2025. (A) Prevalence of T2DM. (B) Annual
number of new T2DM cases. (C) Projected T2DM prevalence among Qataris in five forecast scenarios. In panels A and B, the solid
black linesare theprojections for the total population, the reddashed linesare theprojections formales, and thebluedashed lines
are theprojections for females. InpanelC, the linesshowthefivedifferentprojectionscenariosofeffectsof trends inT2DM-related
risk factors. (For interpretationof the referencestocolor in thisfigure legend, the reader is referredto thewebversionof thisarticle.)
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Fig. 2 – Age-specific characteristics of type 2 diabetes mellitus (T2DM) among Qataris. The figure shows (A) the age-specific
T2DM prevalence (constant between 2012 and 2050), and (B) the age-specific T2DM incidence (annual number of new T2DM
cases) in four different timeframes; 2012, 2030, 2040, and 2050.
Fig. 3 – Projected total health expenditure for type 2 diabetes mellitus (T2DM) among Qataris between 2012 and 2050. The
figure shows the expenditure assuming (A) fixed per capita health expenditure between 2012 and 2050, and (B) differential per
capita health expenditure per year between 2012 and 2050 based on the historical increasing trend of per capita health
expenditure in Qatar as provided by World Bank data [35]. The health expenditure directly attributed to T2DM out of Qatar’s
total healthcare expenditure on Qataris is calculated per the Jo¨nsson’s approach [31] of assuming a ratio of medical care
expenditures for individuals with T2DM to individuals without T2DM in the range between 2 (dashed line) and 3 (solid line).
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We assumed an annual increase of 0.42% in smoking
prevalence [29] and no change in obesity and physical
inactivity.
Scenario 4: Forecast scenario based on increase in physical
inactivityIn absence of reliable trend data on physical inactivity in
Qatar, we assumed that trends in physical inactivity were
similar to trends in obesity. Accordingly, we assumed an
annual increase of 1.05% in physical inactivity prevalence
and no change in obesity and smoking.
Scenario 5: Forecast scenario based on simultaneous trends in all
risk factors
Fig. 4 – Projections for type 2 diabetes mellitus (T2DM) related risk factors among Qataris between 2012 and 2050. The figure
shows projected prevalence of (A) obesity, (B) smoking, and (C) physical inactivity, and proportions of T2DM cases that are
attributable to (D) obesity, (E) smoking, and (F) physical inactivity. The solid black lines are the projections for the total
population, the red dashed lines are the projections for males, and the blue dashed lines are the projections for females. (For
interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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increase simultaneously—i.e. 1.05% increase in obesity and
physical inactivity, and 0.42% increase in smoking.
2.3.2. Projection of health expenditure for T2DM
We used an approach developed by Jo¨nsson to estimate
health expenditures directly attributed to T2DM from a
country’s total health care expenditure (Appendix Text
S1) [31]. Briefly, the relative ratio (Ras) of all health care
expenditures between T2DM and non-T2DM individuals
is the key parameter in the conversion of per capita health
expenditure to estimates of T2DM attributable spending.
Based on evidence, Ras was assumed to be between 2
and 3 [32]. We included the possibility of discounting on
future expenditures. The main outcomes were reported
with no discounting, but for comparison purposes, we
applied an annual discount rate of 3% [33] for some of
the results.
For projections of T2DM attributable national health
expenditure, we applied two assumptions for Qatar’s per cap-
ita health expenditure over time. First, we assumed that per
capita health expenditure remained constant between 2012
and 2050 as estimated in 2012 (i.e. $2270 United States dollars)
[34]. Second, we assumed that per capita health expenditurechanged with time, based on the historical trend of per capita
health expenditure in Qatar as provided by World Bank data
(Appendix Fig. S4) [35].
2.3.3. Sensitivity and uncertainty analyses
Several univariate sensitivity analyses were conducted to
assess robustness of model predictions to variations in rela-
tive risk (RR) of risk factors, RR of mortality in T2DM com-
pared to the general population, and prevalence of physical
inactivity at baseline year. The latter was conducted because
of evidence suggesting that self-reported physical activity is
inflated relative to objective biomarkers [36].
A multivariate uncertainty analysis was also performed
to specify uncertainty ranges in projected prevalence esti-
mates relative to variations in structural parameters of the
model. We used Monte Carlo sampling from log-normal dis-
tributions for confidence intervals or ranges of plausibility of
the epidemiological parameters of the model (Appendix
Table S1). Random values from specified ranges were
selected for the parameters at each run. This set of new
parameters was employed to refit T2DM prevalence. We
implemented 1000 runs of the model and determined the
likelihood distributions and the 95% uncertainty intervals
(UI) for the measures.
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3.1. Projections of T2DM prevalence and incidence
Fig. 1 illustrates the predicted T2DM prevalence and incidence
between 2012 and 2050 among Qataris aged 15–64 years.
Based only on the demographic structure change of Qataris
(Appendix Fig. S3), the prevalence was predicted to increase
from 16.7% in 2012 to 24.0% by 2050 (Fig. 1A). T2DM preva-
lence was higher among males than females; 17.5% in males
compared to 15.9% in females in 2012, and predicted to be
24.9% compared to 22.9%, respectively, by 2050 (Fig. 1A).
Given the population size and its future projection (Appen-
dix Fig. S2), a total of 20,953 Qataris had T2DM in 2012, with
978 new cases (Fig. 1B). The number of T2DM cases was pre-
dicted to increase to 51,921 cases by 2050, with 1907 new
cases in that year.
T2DM prevalence was insignificant in the younger age
groups and increased with age (Fig. 2A). T2DM prevalence
peaked at 35.0% among 55–64 years old and decreased among
those over 65 years old. The rise in T2DM cases in 2012–2050
was most prominent among 45–54 years old (Fig. 2B). The lar-
gest relative increase was found among 75–79 years old:
T2DM cases in 2050 were 3.3 times higher than in 2012.
3.2. Health expenditure for T2DM
In 2012, the total T2DM health expenditure among Qataris
ranged between $38.3 million (for a ratio of health care expen-
diture of Ras = 2) and $66.0 million (Ras = 3; Fig. 3). An average
between $1800 (Ras = 2) and $3103 (Ras = 3) was expected to
have been spent on each T2DM case in 2012.
Assuming a fixed health expenditure per capita per 2012,
total T2DM health expenditure by 2050 was projected to be
more than twice as large as that in 2012 (Fig. 3A); between
$90.0 million (Ras = 2) and $150.3 million (Ras = 3). An average
between $1734 (Ras = 2) and $2895 (Ras = 3) was expected to
be spent on each T2DM case by 2050. Applying an annual dis-
count rate of 3% on future expenditures, total T2DM health
expenditure by 2050 was projected to range between $33.9
million (Ras = 2) and $56.7 million (Ras = 3).
Assuming continuation of the historical trend for per capita
health expenditure in Qatar (Appendix Fig. S4), total T2DM
health expenditure by 2050 was estimated to be about five
times larger than that in 2012 (Fig. 3B); between $241.8 million
(Ras = 2) and $400.8 million (Ras = 3). An average between $4658
(Ras = 2) and $7777 (Ras = 3) was expected to be spent on each
T2DM case by 2050. Applying an annual discount rate of 3%
on future expenditures, total T2DM health expenditure by
2050 was projected to range between $91.2 million (Ras = 2)
and $152.2 million (Ras = 3).
3.3. Projections of T2DM-related risk factors
Fig. 4A–C illustrates the predicted prevalence of T2DM-related
risk factors based only on the demographic structure change
of Qataris. Prevalence of obesity, smoking, and physical inac-
tivity was 41.4%, 16.4%, and 45.9%, respectively in 2012, and
increased to 51.0%, 19.4%, and 53.0%, respectively by 2050.Prevalence of obesity, smoking, and physical inactivity dif-
fered by sex. Males had much higher smoking prevalence
compared to females: 30.5% versus 1.0% in 2012 and 35.3%
versus 1.2% by 2050 (Fig. 4B). However, females had higher
obesity prevalence compared to males: 43.2% versus 39.3%
in 2012, and 53.4% versus 48.3% by 2050 (Fig. 4A). Similarly,
females had higher physical inactivity rates compared to
males: 54.2% versus 37.4% in 2012, and 60.7% versus 45.2%
by 2050 (Fig. 4C).
3.4. Proportion of T2DM cases attributable to risk factors
Fig. 4D–F shows the proportions of T2DM cases among Qataris
that are attributed to obesity, smoking, and physical inactiv-
ity. In 2012, T2DM incident cases attributed to obesity, smok-
ing and physical inactivity were 57.5%, 1.8%, and 5.4%,
respectively. By 2050, the proportions were projected to
increase to 65.7%, 2.1%, and 6.0%, respectively. The propor-
tions of T2DM cases attributable to risk factors differed by
sex and are illustrated in Fig. 4D–F.
3.5. Effects of future trends in risk factors on T2DM
Fig. 1C and Appendix Table S2 quantify the effects of future
trends in T2DMrelated risk factors on T2DM prevalence by
2050. Four forecast scenarios were compared to the baseline
scenario of constant age-specific distribution for the risk fac-
tors (Scenario 1). In the baseline scenario, T2DM prevalence
reached 24.0% by 2050. The predicted T2DM prevalence by
2050 was slightly higher in Scenario 3 (24.4%), in which only
smoking prevalence increased, and in Scenario 4 (24.5%), in
which only physical inactivity increased. However, the pre-
dicted T2DM prevalence was considerably higher in Scenario
2 (32.4%), in which only obesity increased, and was highest
in Scenario 5 (37.8%), in which all risk factors increased simul-
taneously. Of notice, as risk factors act simultaneously in
overlapping compartments, their individual effect changes
as the RRs are combined multiplicatively, thereby amplifying
their effects on T2DM prevalence.
4. Discussion
We introduced a novel analytical mathematical modeling
approach to investigate T2DM epidemiology, assess the role
of key risk factors and their overlap in driving T2DM inci-
dence and prevalence, and forecast T2DM-related health
expenditures. The new model is an improvement to previous
studies as it captures dynamically interactions and trends of
risk factors, demography, and T2DM natural history. The
model predicts T2DM over decades and provides a framework
for generating strategic information to inform T2DM public
health policy, programming and resource allocation at the
national level. We applied the model to Qatar, a high-
burden T2DM country, as an example, but can be applied
across countries. The approach also offers a platform for
extensions to assess the impact and cost-effectiveness of
interventions against T2DM and risk factors.
Armed with nationally-representative population-based
data, we projected T2DM burden in the Qatari population
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prevalence in Qatar was projected to increase by at least
43%, in the most optimistic scenario, despite being already
over twice the global average. Factoring in population growth
and aging, the number of people with T2DM was projected to
grow by 147% by 2050. Though T2DM health expenditure is
already consuming nearly 20% of national health expendi-
ture, it is projected to reach 32% by 2050. These findings high-
light the urgency for cost-effective preventive and therapeutic
interventions for T2DM and its risk factors as a national pri-
ority in Qatar.
A striking finding is that T2DM prevalence is driven by the
high prevalence of obesity in this nation (41.4% in 2012).
Smoking and physical inactivity contributed to T2DM’s high
and growing levels. While less than 10% of T2DM cases were
attributed to smoking and physical inactivity combined,
nearly 60% were attributed to obesity, and more so for
females thanmales. If obesity prevalence among Qataris aged
20–79 years in 2012 was as low as that in Japan (around 4%
[37]), T2DM prevalence would have decreased from 16.7% to
9.8% and stood at two percentage points higher than that in
Japan (7.6% [38]; Appendix Fig. S5)—highlighting obesity as
the leading driver of the T2DM epidemic in Qatar.
Demography influences the growing T2DM epidemic over
the coming decades. The Qatari population was projected to
grow by 73% between 2012 and 2050 (Appendix Fig. S2). A
fairly rapid aging of this population (Appendix Fig. S3) leads
to higher T2DM prevalence through its direct effect on
T2DM, and its indirect effect on the risk factors that drive
T2DM incidence. Obesity, for example, was projected to
increase by 23% between 2012 and 2050 due to population
aging (Fig. 4). If the prevalence of risk factors will increase
due to factors other than population aging, our baseline pro-
jections will underestimate future T2DM prevalence. For
example, an annual 1.05% increase in obesity, would result
in an 8.5 percentage points increase in T2DM prevalence by
2050, from 24.0% to 32.3%.
There has been a debate about the role of genetic factors
in Qatar’s rising T2DM epidemic [39,40]. Our study indicates
that more than two-thirds of T2DM incidence is attributed to
modifiable risk factors including obesity, smoking and phys-
ical inactivity (Fig. 4). Genetic factors may have a significant
role in T2DM epidemiology, but are not the main drivers of
T2DM in Qatar. A public health focus on modifiable risk fac-
tors may prevent or even reverse the rising T2DM burden.
Evidence indicates that lifestyle interventions can prevent
the progression of impaired glucose tolerance, and therefore
reducing the projected rise in T2DM prevalence [41,42]. The
Finnish Diabetes Prevention Study has demonstrated that
such preventive measures can lead to a 40% decrease in
T2DM incidence [42]. Further to individual-based approaches
that rely on behavioral change, population-based strategies
such as taxation and marketing restrictions may prove to
be more impactful [43]. However, adapting and testing such
approaches to the Qatari context require further research
on the feasibility and practicality of intervening against
modifiable risk factors, such as physical activity, but this
research continues to be underdeveloped in Qatar and the
region [44].Our projections for the rise of T2DM among Qataris are
lower than those reported by the International Diabetes Fed-
eration (IDF) [45]. IDF estimated T2DM prevalence for those
aged 20–79 at 13.5% in 2015 and at 21.0% in 2040—an increase
of 56% [45]. Our study predicts an increase of 26%, from 16.7%
in 2015 to 21.1% in 2040. IDF uses a logistic regression method
for estimation rather than a dynamical population-level
model, and uses data from Qatar’s neighboring countries for
its projections [46–51], while we parameterized our model
using Qatar’s population-based data.
Our predictions are consistent with the increasing T2DM
in MENA, and in the Arabian Gulf countries in particular
[45]. T2DM prevalence among Qataris is similar to other
neighboring countries including Bahrain (15.6%), Saudi Arabia
(17.6%), Kuwait (14.3%), and the United Arab Emirates (14.6%)
[45].
Limitations may have affected our results. Although we
used an elaborate mathematical model to capture the com-
plexity of T2DM dynamics, our predictions may depend on
the type of mathematical model used. Our predictions rely
on availability of representative epidemiological, demo-
graphic and economic data for T2DM, but limitations in
input data can lead to limitations in model predictions.
There has been one nationally-representative population-
based survey in Qatar for T2DM and its risk factors [13],
however, the precision of our projections would have been
enhanced, if more trend data were available. In the STEPwise
survey, fasting capillary blood glucose testing was used as
opposed to venous testing, but data suggests reliability of
capillary testing for measuring T2DM prevalence [52]. The
relative ratio of healthcare expenditure between T2DM and
non-T2DM individuals has not been formally assessed in
Qatar. However, this ratio has been assessed for other coun-
tries in the range of 2–3 [31], and we used this range to
bracket our estimate for T2DM economic burden. Estimates
of the RRs associated with the three risk factors were
obtained from large, recent systematic reviews which were
global in scope, but it is possible that their magnitude may
be different in Qatar.
Given potential limitations and to assess the reliability
of our predictions, we conducted several sensitivity analy-
ses (Appendix Fig. S7). These analyses demonstrated that
our results are sensitive to the RR of developing T2DM
if obese, as expected given that nearly 60% of T2DM is
attributed to obesity. The analyses have also shown sensi-
tivity to large biases in self-reported prevalence of physi-
cal inactivity, highlighting the need for use of objective
biomarkers in physical activity surveys. Otherwise our
results were insensitive to variations in the rest of
explored parameters.
Given the sensitivity to the RRs of developing T2DM, we
conducted a multivariate uncertainty analysis to assess the
uncertainty in model output given the uncertainty in
model input for the RRs of risk factors and other parame-
ters (Appendix Fig. S6). The results demonstrated narrow
UIs around our point estimates, thanks to the narrow
95% CIs around the input parameters. Therefore, the sensi-
tivity and uncertainty analyses affirmed the validity of our
predictions.
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We developed and demonstrated the utility of an analytical
approach to investigate T2DM epidemiology, drivers of
T2DM incidence and economic burden, and to provide a
strategic framework to inform public health policy, program-
ming and resource allocation. Themodel was applied to Qatar
where we predicted a rising T2DM epidemic driven by popula-
tion growth and aging, and growing levels of risk factors.
Importantly, we found that obesity is the driver of over half
of T2DM incidence among Qataris, and that at least one-
third of Qatar’s health expenditure is destined to be spent
on T2DM by 2050. These expenditures should be seen in con-
text of the wider burden of T2DM on individuals, their fami-
lies, and society in terms of premature departure from the
workforce, reduced quality of life, and early mortality. The
high cost of T2DM even in a wealthy country like Qatar should
receive the attention that it deserves.
These findings highlight the urgency for introduction and
expansion of cost-effective preventive and therapeutic inter-
ventions targeting T2DM and its modifiable risk factors as a
national priority. If effectively implemented, lifestyle inter-
ventions can prevent or even reverse the expansion of this
epidemic in a nation that is already burdened by this disease.
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